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of rotation is exhaustively searched on a grid of 9 different 
points separated by 1cm from the center of the insertion 
area (Figure 1b). For the needle angulation, the method by 
Poulin (2013) for parallel needle positioning was adapted as 
follows: a heuristic is determined by projecting the planning 
target volume (PTV) from the center of rotation into a 
transverse plane and k-means clustering on the indices of the 
latter surface is applied (Figure 1c). The dwell time is 
determined by the resolution of linear equations following a 
similar method described by Goldman (2009) for external 
beam radiotherapy, called Fast Inverse Dose Optimization 
(FIDO). To test this optimizer, a planning study for focal 
prostate brachytherapy was performed. The optimal 
parameters were determined to obtain the desired coverage 
(PTV D95 of 19 Gy) without exceeding the constraints of the 
organs at risk (D10% urethra of 21 Gy, D1 cc bladder and 
rectum of 12 Gy). The dose distribution was calculated on 10 
patients (PTV volumes ranged from 8,5cc to 23,3cc with a 
median of 16,1cc) for 2, 4, 6, 8, 10, 12 and 14 needles by 
using the earlier mentioned constraints as input.  
Results: The average coverage (D95 of PTV) and the dose on 
the organs at risk (D10% urethra, D1cc of bladder and rectum) 
for all 10 patients are depicted in Figure 1d. The quality of 
the dose plan increases with the number of needle insertions. 
On average, a clinical acceptable plan is already reached by 
using four needle insertions. The complete optimization 
workflow took less than 20 minutes on a PC with a 3.10GHz 
Intel® CoreTM i5-2400 processor and 8GB RAM using MATLAB 
R2013a. 
Conclusions: The efficacy of the automated optimization tool 
was demonstrated for focal HDR prostate brachytherapy with 
divergent needles. On average, clinically acceptable plans 
were achieved using 4 needles or more. 
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Purpose/Objective: To determine whether a real-time 3D-
ultrasound (3DUS) imaging improves brachytherapy structure 
delineations for cervical cancer. 
Materials and Methods: MRI, CT, 3DUS (Clarity AutoScan, 
Elekta, Montreal) and CT-3DUS fusion were all used for 
imaging the structures of interest (HR-CTV, cervix, uterus 
and rectum/sigmoid) for cervical cancer brachytherapy 
treatments of 8 consecutive patients. MRI images were 
acquired prior to brachytherapy following EBRT. 3DUS was 
performed simultaneously to the CT planning in the 
treatment room. Fusion between 3DUS and CT was performed 
on the Clarity workstation and the contours were traced 
using the OncentraBrachy planning system (Elekta). 
Coutouring was done by 3 physicians: 2 radiation oncologists 
(RO1 and RO2) and 1 diagnostic radiologist (DR) specialised in 
gynaecology. MRI contours traced by the DR were used as the 
reference set even though the applicators were not yet in 
place. The cervix and the HR-CTV were contoured three 
times by the DR to validate the stability of the reference. 
The absolute volumes and the transverse and longitudinal 
dimensions of the HR-CTV were compared with the reference 
for each imaging modality and physician. 
Results: As expected the CT volumes are larger than MRI 
(Table 1). The MRI contours of the DR and the ROs are 
significativally larger than the intra-observer variability. The 
difference comes from the fact that ROs include treatment 
considerations, which is not the case with the DR. The 3DUS 
volumes are closer to the MRI volumes for each physician, but 
standard deviations are the largest (32% to 42%). CT-3DUS 
fusions keep the benefit of 3DUS alone for volume denifition 
while reducing significantly the variability for each physician. 
The variation in longitudinal dimension of the contours was 
found to have the largest impact on both inter-observers and 
inter-modalities differences in volumes.  
 
Conclusions: Generally, 3DUS allows for contours closer to 
MRI, but offers little information on the OARs. The CT-3DUS 
helps to get that extra information and offers, in axial slices, 
contours closer to MRI in all cases for the ROs compared to 
the CT alone. The learning curve of 3DUS could also explain 
the large standard deviation seen. This technology is 
promising and requires further investigation to determine its 
usefulness in treatment planning.  
   
PD-0181   
Image-guided adaptive brachytherapy for cervix cancer: 
higher target dose by increasing planning aim 
A. Li1, L.H. Djupvik1, K. Bruheim2, E. Nakken2, K. Skipar2, T.P. 
Hellebust1 
1DNR - Norwegian Radium Hospital, Department of Medical 
Physics, Oslo, Norway  
2DNR - Norwegian Radium Hospital, Department of Oncology, 
Oslo, Norway  
 
S90                                                                                                                                         3rd ESTRO Forum 2015 
 
Purpose/Objective: Image-guided adaptive brachytherapy 
(IGABT) is increasingly implemented as a treatment modality 
for patients with cervical cancers. The use of intercavitary 
(IC) and interstitial (IS) implants enables higher conformance 
of target dose and sparing of organs at risk (OAR). Until 
August 2014 our planning aim for HR-CTV D90 was 81 Gya/b=10 . 
Data from the EMBRACE study suggests that the planning aim 
should be above 85Gya/b=10 and in September 2014 this was 
implemted in our clinic. In this retrospective analysis data 
from 19 patients subjected to the new planning aim were 
compared with data from patients treated before September 
2014.  
Materials and Methods: Since September 2014 19 patients 
have been treated with conformal external beam 
radiotherapy (EBRT) to 50.4 Gy in 28 fractions in combination 
with IGABT, using 5 or 4 fractions with a planning aim of 5.5 
Gy or 6.5 Gy, respectively. For each brachyterapy fraction 3D 
image-guided treatment planning was performed to optimize 
the dose to the target volumes while keeping the dose to the 
OARs as low as possible. Dose-volume-histogram parameters 
for the target volumes and the OARs were recorded for each 
fraction and EQD2 total doses were calculated.The dose-
volume-histogram parameters for this patient cohort were 
compared with a patient cohort of 147 patients treated prior 
to September 2014. The latter cohort were treated with EBRT 
to a total dose of 50 Gy in 25 fractions in combination with 
IGABT, using 5 fractions with a planning aim of 5 Gy per 
fraction. 
Results: Figure 1 shows the percentage of patients that 
received HR-CTV D90>81, >85, >87, >90 Gya/b=10, with and 
without needles when the HR-CTV planning aim was 81 
Gya/b=10 and 85Gya/b=10. For the lower planning aim the fraction 
of the patients treated with HR-CTV D90>81 Gya/b=10, D90>85 
Gya/b=10, D90>87 Gya/b=10 and D90>90 Gya/b=10 was 86%, 61%, 
46% and 34%, respectively. For the higher planning aim these 
figures increased to 95%, 90%, 68% and 36%. The largest 
improvement was seen for the percentage of patients 
receiving D90>85 Gya/b=10. For the patients treated without 
needles, we were able to achieve D90>85 Gya/b=10 for all the 
patients, compared to 69% when we used the lower planning 
aim. For patients treated with needles, we were able to 
achieve D90>85 Gya/b=10 for 83% of the patients, compared to 
45% when we used the lower planning aim. Table 1 shows 
that the dose to the OARs are unchanged for both planning 
aims, which proves that we were able to increase the target 
dose without increasing the dose to the OARs. Needles were 
used in at least one fraction for 36% of the patients when the 
planning aim was 81 Gya/b=10 compared to 63%, when the 
planning aim was 85 Gya/b=10. 
 
 
 
 
 
 
 
Conclusions: When the planning aim was increased, we were 
able to increase the target dose while keeping the doses to 
the OARs unchanged. Increasing the planning aim improved 
the quality of the dose distribution. This was either achieved 
by improving the dose optimalization, by implanting more 
patients with needles or by using a higher number of needles 
per implant. 
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Purpose/Objective: The Utrecht applicator (Elekta, 
Veenendaal, the Netherlands) used in the brachytherapy (BT) 
treatment of cervixcarcinoma has the possibility to include 
up to 10 interstitial needles along with the intra-uterine and 
ovoid channels. The choice of needles and their insertion 
depth in the first fraction is based on discussion amongst 
radiation oncologists, medical physicists and RTTs, the so-
called 'expert opinion', making use of the MRI scan (without 
applicator in place) recorded in week 3 or 4 of external beam 
radiotherapy (EBRT) (pre-MRI). The purpose of this study is to 
investigate whether a pre-MRI simulation can predict more 
accurately which needles are best suited for use in the first 
BT fraction.  
Materials and Methods: For 5 patients the high risk CTV (HR-
CTV) was delineated on the pre-MRI. Using the 'applicator 
modeling' functionality the applicator was simulated on the 
MRI, the so-called 'pre-plan'. The applicator model was 
correctly placed virtually, and the needles which obviously 
entered the HR-CTV were reconstructed. Needles were then 
discarded based on a few criteria. Only needles with more 
than one active source position well within the HR-CTV were 
included. Furthermore, needle positions always avoided in 
